ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Revenue

ANI Pharmaceuticals had revenue of $148.33M in the quarter ending September 30, 2024, with 12.52% growth. This brings the company's revenue in the last twelve months to $555.46M, up 23.60% year-over-year. In the year 2023, ANI Pharmaceuticals had annual revenue of $486.82M with 53.87% growth.

• Revenue (ttm): $555.46M
• Revenue Growth: +23.60%
• P/S Ratio: 2.02
• Revenue / Employee: $865,196
• Employees: 642
• Market Cap: 1.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	486.82M	170.43M	53.87%
Dec 31, 2022	316.39M	100.25M	46.38%
Dec 31, 2021	216.14M	7.66M	3.67%
Dec 31, 2020	208.48M	1.93M	0.93%
Dec 31, 2019	206.55M	4.97M	2.47%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.